Wed, November 2, 2011
[ Wed, Nov 02nd 2011 ] - Market Wire
Threshold Pharmaceuticals Appoints Nipun Davar as .. t of Pharmaceutical Development and Manufacturing
Tue, November 1, 2011
[ Tue, Nov 01st 2011 ] - Market Wire
Anthera Pharmaceuticals Reports 2011 Third Quarter Financial Results and Operational Update
[ Tue, Nov 01st 2011 ] - Market Wire
Solta and Medicis Announce Close of Agreement for LIPOSONIX
[ Tue, Nov 01st 2011 ] - Market Wire
INSYS Therapeutics Announces Commercial Team Additions
[ Tue, Nov 01st 2011 ] - Market Wire
Theravance to Present at Investor Conferences in November 2011
[ Tue, Nov 01st 2011 ] - Market Wire
ISTA Pharmaceuticals Reports Third Quarter 2011 Financial Results
[ Tue, Nov 01st 2011 ] - Market Wire
Critical Outcome Technologies Inc. to Deliver Pod .. on on COTI-2 at Influential Scientific Conference
[ Tue, Nov 01st 2011 ] - Market Wire
Syneron Sets New Facial Rejuvenation Standard Wit .. t the American Society of Dermatologic Surgery Co
[ Tue, Nov 01st 2011 ] - Market Wire
Immunovaccine to Report Q3 2011 Financial Results and Conference Call
[ Tue, Nov 01st 2011 ] - Market Wire
RepliCel Provides Update on First-in-man Clinical Trials and Recent Corporate Activity
[ Tue, Nov 01st 2011 ] - Market Wire
Equity Research on Pharmaceutical Product Develop .. cs Inc. - Acquisitions and Privatizations Dominat
[ Tue, Nov 01st 2011 ] - Market Wire
Aeolus Pharmaceuticals Announces Positive Results .. Neupogen(R) as Combination Therapy for Treatment
[ Tue, Nov 01st 2011 ] - Market Wire
Cytokinetics Announces Initiation of Second Cohor .. l Trial Evaluating CK-2017357 in Patients With AL
[ Tue, Nov 01st 2011 ] - Market Wire
VentriPoint Commences Clinical Studies of Pulmona .. ension Application of Right Heart Analysis System
[ Tue, Nov 01st 2011 ] - Market Wire
Imaging3, Inc. FDA 510(k) Protocol Meeting Update
[ Tue, Nov 01st 2011 ] - Market Wire
SciClone Pharmaceuticals to Report Third Quarter 2011 Financial Results on November 8
[ Tue, Nov 01st 2011 ] - Market Wire
Implant Sciences' Explosives Trace Detector Deployed at Middle East Embassy
[ Tue, Nov 01st 2011 ] - Market Wire
Reflect Scientific, Inc. Strengthens Liquid Nitrogen Cooling Intellectual Property Position
[ Tue, Nov 01st 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the Lazard Healthcare Conference
Mon, October 31, 2011
[ Mon, Oct 31st 2011 ] - Market Wire
Santarus Announces Presentation of Pooled Data fr .. linical Studies at the ACG Annual Scientific Meet
[ Mon, Oct 31st 2011 ] - Market Wire
Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey
[ Mon, Oct 31st 2011 ] - Market Wire
Genie Energy Begins Trading on NYSE
[ Mon, Oct 31st 2011 ] - Market Wire
Exelixis to Initiate Cabozantinib a306 Trial with Pain Endpoint in mCRPC
[ Mon, Oct 31st 2011 ] - Market Wire
SRI/Surgical Express Third Quarter 2011 Conference Call
[ Mon, Oct 31st 2011 ] - Market Wire
Merck Announces Dates for R&D and Business Briefi .. and Fourth-Quarter 2011 Sales and Earnings Report
[ Mon, Oct 31st 2011 ] - Market Wire
00 p.m. ET to Discuss Financial Results for the T .. Quarter and Nine Months Ended September 30, 2011
[ Mon, Oct 31st 2011 ] - Market Wire
NPS Pharmaceuticals to Host Conference Call to Di .. can College of Gastroenterology Annual Scientific
[ Mon, Oct 31st 2011 ] - Market Wire
Medtronic Receives First FDA Approval of Cobalt C .. Expandable Stent to Treat Narrowed Iliac Arteries
[ Mon, Oct 31st 2011 ] - Market Wire
PharmStar to Pursue SEC Fully-Reporting Status
[ Mon, Oct 31st 2011 ] - Market Wire
Teva Presents New Data on QNASLa" at the 2011 Ame .. of Allergy, Asthma and Immunology Annual Meeting
[ Mon, Oct 31st 2011 ] - Market Wire
CytRx Announces Favorable Initial Results from it .. nical Trial in Patients with Soft Tissue Sarcomas
[ Mon, Oct 31st 2011 ] - Market Wire
Health Net Named to USO-Metroas Circle of Stars
[ Mon, Oct 31st 2011 ] - Market Wire
Trimel Initiates Dosing in Phase III Trial of CompleoTRT in Male Hypogonadal Patients
[ Mon, Oct 31st 2011 ] - Market Wire
Given Imaging Announces New Studies Validate Use .. llCam SB(R) to Detect and Monitor Crohn's Disease
[ Mon, Oct 31st 2011 ] - Market Wire
Teleflex Launches New Website for Teleflex ISIS HVTa", the First Comprehensive Endotracheal Tube
[ Mon, Oct 31st 2011 ] - Market Wire
Illumina Names Dr. Daniel S. Grosu Chief Medical Officer
[ Mon, Oct 31st 2011 ] - Market Wire
Winner Medical Ranked High by CNTAC
Sat, October 29, 2011
[ Sat, Oct 29th 2011 ] - Market Wire
Gilead presenta solicitud de nuevo frmaco a la FD .. "Quad" de nica pastilla una vez al da para el VIH
Fri, October 28, 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Almost Family, Inc. to Report Third Quarter 2011 Financial Results on November 2, 2011
[ Fri, Oct 28th 2011 ] - Market Wire
The Ensign Group Schedules Third Quarter 2011 Earnings Call for Thursday, November 3, 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
[ Fri, Oct 28th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company
[ Fri, Oct 28th 2011 ] - Market Wire
Ergoresearch Ltd Reports Growing Sales of 9.0% fo .. 30, 2011. Earnings Before Tax for the Period Amou
[ Fri, Oct 28th 2011 ] - Market Wire
ZIOPHARM Presents Promising Preclinical Pediatric .. nd IV Palifosfamide at the 2011 CTOS/MSTS Meeting
[ Fri, Oct 28th 2011 ] - Market Wire
Medtronic Receives IDE Approval to Conduct ASPIRE .. sulin Pump with Low Glucose Suspend for US Market
[ Fri, Oct 28th 2011 ] - Market Wire
MannKind Corporation to Hold 2011 Third Quarter F .. ncial Results Conference Call on November 3, 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Advaxis Receives Additional Financing
[ Fri, Oct 28th 2011 ] - Market Wire
The Medicines Company and Daiichi Sankyo Announce Angiox(R) (Bivalirudin) Co-Promotion for Germany
[ Fri, Oct 28th 2011 ] - Market Wire
What's Ahead: Today's Economic Outlook - Equity R .. Mylan Inc. and Medicis Pharmaceutical Corporation
[ Fri, Oct 28th 2011 ] - Market Wire
Egan-Jones Recommends Poniard Shareholders Vote " .. osed Merger With ALLOZYNE and Reverse Stock Split
[ Fri, Oct 28th 2011 ] - Market Wire
Analyst Research on Sequenom Inc. and Life Techno .. Companies Succeeding in Bringing Products to the
[ Fri, Oct 28th 2011 ] - Market Wire
Pfizer Completes Acquisition Of Icagen
[ Fri, Oct 28th 2011 ] - Market Wire
Gilead deposita una domanda di approvazione di nu .. per gli Alimenti e i Medicinali statunitense (Foo
[ Fri, Oct 28th 2011 ] - Market Wire
Salix Pharmaceuticals Previews American College of Gastroenterology 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Gilead stellt Zulassungsantrag bei der FDA fr neu .. r HIV-Therapie mit tglich einer einzigen Tablette
[ Fri, Oct 28th 2011 ] - Market Wire
Threshold Pharmaceuticals Reports Further Promising Data With TH-302 in Soft Tissue Sarcoma
Thu, October 27, 2011
[ Thu, Oct 27th 2011 ] - Market Wire
Unity Powers Army OneSource Virtual World
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec en Portola Pharmaceuticals kondigen i .. n voor oraal syk-remmerprogramma gericht op auto-
[ Thu, Oct 27th 2011 ] - Market Wire
Pfizer Declares A 20-Cent Fourth-Quarter 2011 Dividend
[ Thu, Oct 27th 2011 ] - Market Wire
Crystal Research Associates, LLC Issues Executive .. al Overview (EIO) on Adamis Pharmaceuticals Corp.
[ Thu, Oct 27th 2011 ] - Market Wire
FMX Ventures Inc. and Tolima Gold Corp. Announce .. or and Commencement of Private Placement Offering
[ Thu, Oct 27th 2011 ] - Market Wire
Cannabis Science Releases First Cannabis-Extract- .. Now at Cannabis Therapeutics, 957 E. Fillmore St,
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec e Portola Pharmaceuticals hanno annun .. ale per Oral Syk, il programma inibitore specific
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec et Portola Pharmaceuticals annoncent .. ns le cadre daun programme dainhibiteur oral de l
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec und Portola Pharmaceuticals verknden .. rogramm fr den oral verabreichten SYK-Inhibitor b
[ Thu, Oct 27th 2011 ] - Market Wire
Health Net Federal Services Launches Mobile Site .. he-Go Access to Health Care for Military Families
[ Thu, Oct 27th 2011 ] - Market Wire
Human Genome Sciences and Xoma Fall Victim to Volatile Nature of Biotech Sector
[ Thu, Oct 27th 2011 ] - Market Wire
PharmaGap Sets Time for in Vivo Tests
[ Thu, Oct 27th 2011 ] - Market Wire
Dynavax Phase 3 Data in Chronic Kidney Disease De .. rates Superiority of HEPLISAV(TM) vs Engerix-B(R)
[ Thu, Oct 27th 2011 ] - Market Wire
Implant Sciences Explosives Detection Technology Protects Major European Bank
[ Thu, Oct 27th 2011 ] - Market Wire
Incyte Reports Third Quarter 2011 Financial Results and Provides Update on Key Clinical Programs
[ Thu, Oct 27th 2011 ] - Market Wire
Acorda Therapeutics to Host Conference Call to Di .. uarter 2011 Financial Results on November 4, 2011
[ Thu, Oct 27th 2011 ] - Market Wire
ICON Reports Q3 revenue growth of 7% to $241 mill .. f $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)
[ Thu, Oct 27th 2011 ] - Market Wire
Pfizer Receives European Approval to Extend Use o .. ars and Older for the Prevention of Invasive Pneu
Wed, October 26, 2011
[ Wed, Oct 26th 2011 ] - Market Wire
Universal American Corp. Reports Third Quarter 2011 Results
[ Wed, Oct 26th 2011 ] - Market Wire
Baxter to Present at the Credit Suisse 2011 Healthcare Conference
[ Wed, Oct 26th 2011 ] - Market Wire
Medtronic Starts Landmark Study of Hypertension Treatment
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec oglasza pozytywne podsumowanie wynikw .. 3. badan nad doustnym BG-12 u pacjentw ze stward
[ Wed, Oct 26th 2011 ] - Market Wire
Stellar Biotechnologies &;; Life Diagno .. e Agreement for Stellar Brand KLH ELISA Test Kits
[ Wed, Oct 26th 2011 ] - Market Wire
2011 Third Quarter and Nine-Month Results
[ Wed, Oct 26th 2011 ] - Market Wire
Seattle Genetics Appoints Vice President, Medical .. nces Vice President, Quality Management Promotion
[ Wed, Oct 26th 2011 ] - Market Wire
Abiomed to Release New Protect II Data and Econom .. #59; Over 20 Impella Presentations Included i
[ Wed, Oct 26th 2011 ] - Market Wire
Health Canada Clears Immunovaccine for Ovarian Cancer Vaccine Trials
[ Wed, Oct 26th 2011 ] - Market Wire
Cytori to Webcast Third Quarter Financial Results November 3
[ Wed, Oct 26th 2011 ] - Market Wire
Magellan Health Services Joins with Share Our Strength to End Childhood Hunger in America
[ Wed, Oct 26th 2011 ] - Market Wire
Octapharma Locks-in Binding Forecast to Exceed $2M for ProMetic's Prion Capture Resin for H1 2012
[ Wed, Oct 26th 2011 ] - Market Wire
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
[ Wed, Oct 26th 2011 ] - Market Wire
Covidien Launches Worldas First Non-Absorbable, Uni-Directional Knotless Suture
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec annonce des rsultats trs positifs l'i .. se 3 tudiant BG-12 (dimthylfumarate) administr pa
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec annuncia risultati preliminari positi .. ico di fase III del farmaco orale BG-12 (dimetilf
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec Announces Positive Top-Line Results f .. stigating Oral BG-12 (Dimethyl Fumarate) in Multi
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec meldet positive Topline-Ergebnisse au .. zur Prfung von oral verabreichtem BG-12 (Dimethyl
Tue, October 25, 2011
[ Tue, Oct 25th 2011 ] - Market Wire
West to Host 2011 Third Quarter Conference Call
[ Tue, Oct 25th 2011 ] - Market Wire
CytoSorbents Corporation to Present at the IN3 Medical Device Summit
[ Tue, Oct 25th 2011 ] - Market Wire
Bard Announces Agreement to Acquire Medivance, Inc.
[ Tue, Oct 25th 2011 ] - Market Wire
USANA Health Sciences Reports Third Quarter 2011 Financial Results
[ Tue, Oct 25th 2011 ] - Market Wire
Micro Imaging Technology Receives a Substantial Exclusive Licensing Proposal From EPIC Corporation
[ Tue, Oct 25th 2011 ] - Market Wire
Daniel Levangie Appointed to Insulet's Board of Directors
[ Tue, Oct 25th 2011 ] - Market Wire
The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in K-V Pharmaceutical Company o
[ Tue, Oct 25th 2011 ] - Market Wire
VistaGen Therapeutics Reports Identification of C .. ts High-Yield Purification of Human Pluripotent S
[ Tue, Oct 25th 2011 ] - Market Wire
Amarantus BioSciences Appoints Dr. Owen Garrick as Strategic Advisor
[ Tue, Oct 25th 2011 ] - Market Wire
What's Ahead: Today's Economic Outlook - Equity R .. earch on Thoratec Corporation and C.R. Bard, Inc.
[ Tue, Oct 25th 2011 ] - Market Wire
Daxor Announces Filing of Patents for Total Body Albumin Analyzer
[ Tue, Oct 25th 2011 ] - Market Wire
OmniGuide Appoints Scott Flora as President & CEO
[ Tue, Oct 25th 2011 ] - Market Wire
ZYTO Corp Appoints Leading Experts to Scientific Advisory Board
[ Tue, Oct 25th 2011 ] - Market Wire
Implant Sciences Sells Follow-On Order to China's Beijing Subway System
[ Tue, Oct 25th 2011 ] - Market Wire
Gilead e GlobeImmune annunciano un contratto di l .. o sviluppo di vaccini terapeutici per il trattame
[ Tue, Oct 25th 2011 ] - Market Wire
Dr. Reddyas Q2 FY12 Financial Results
[ Tue, Oct 25th 2011 ] - Market Wire
Exelixis Appoints Executive Vice President and Chief Commercial Officer
[ Tue, Oct 25th 2011 ] - Market Wire
DaVita Announces Government Inquiry
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
Merck Announces Presentation of Phase III Investi .. ULERA (mometasone furoate and formoterol fumarate
[ Mon, Oct 24th 2011 ] - Market Wire
Blinded Results From Low Dose Cohort of Phase II SHIGATEC Trial Presented at IDSA Annual Meeting
[ Mon, Oct 24th 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Adolor Corporation
[ Mon, Oct 24th 2011 ] - Market Wire
Harwood Feffer LLP Announces Investigation of HealthSpring Inc.
[ Mon, Oct 24th 2011 ] - Market Wire
Edison Expands Cell Therapy Sector Presence with Launch of Research Coverage on Aastrom
[ Mon, Oct 24th 2011 ] - Market Wire
Diligent Boardbooks Announces Fifth Consecutive R .. r, Boardbooks Now Used by 62 TSX Listed Companies
[ Mon, Oct 24th 2011 ] - Market Wire
Syneron Medical to Report Third Quarter 2011 Financial Results on November 10, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
What's Ahead: Today's Economic Outlook - Equity R .. Ware International Inc and St. Jude Medical, Inc.
[ Mon, Oct 24th 2011 ] - Market Wire
Growing Safety Concerns Weigh on Medical Equipment and Supplies Sector
[ Mon, Oct 24th 2011 ] - Market Wire
NPS Pharmaceuticals Reports Upcoming Presentation .. ege of Gastroenterology Annual Scientific Meeting
[ Mon, Oct 24th 2011 ] - Market Wire
Cigna to Acquire HealthSpring
[ Mon, Oct 24th 2011 ] - Market Wire
PharmaGap Chooses Ovarian Cancer as Target for First Clinical Trials
[ Mon, Oct 24th 2011 ] - Market Wire
Research on GlaxoSmithKline plc and Merck &;; Co. Inc. -- Big Pharma Stable for Now
[ Mon, Oct 24th 2011 ] - Market Wire
SecureAlert, Inc. Achieves Milestone of Deploymen .. Units of Its Newest ReliAlert(TM) GPS Tracking a
[ Mon, Oct 24th 2011 ] - Market Wire
Aeolus Pharmaceuticals Announces NIH Counteract G .. 10150 as a Treatment Against Nerve Agent Exposure
[ Mon, Oct 24th 2011 ] - Market Wire
Novadaq to Release Q3-2011 Financial Results on November 4-Conference Call to Follow
[ Mon, Oct 24th 2011 ] - Market Wire
Waters Recognizes the Dr. Ganesh Anand Laboratory .. l University of Singapore as Center of Innovation
Sat, October 22, 2011
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec und Abbott prsentieren positive Daten .. ase-IIb-Studie SELECT auf dem ECTRIMS/ACTRIMS-Kon
[ Sat, Oct 22nd 2011 ] - Market Wire
Zimmer presenta il sistema a vite pedicolare Path .. minimamente invasivo destinato al mercato europeo
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec en Abbott presenteren positieve resul .. P uit Select fase 2b onderzoek op ECTRIMS/ACTRIMS
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec et Abbott pr©sentent les r©sultats .. phase 2b pour le Daclizumab HYP lors du congrs EC
Fri, October 21, 2011
[ Fri, Oct 21st 2011 ] - Market Wire
Kahn Swick &;; Foti, LLC and Former Lou .. nce Securities Class Action Lawsuit Against K-V P
[ Fri, Oct 21st 2011 ] - Market Wire
Data From Phase 2 Clinical Studies of Telotristat .. rcinoid Syndrome to be Presented at North America
[ Fri, Oct 21st 2011 ] - Market Wire
Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
[ Fri, Oct 21st 2011 ] - Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against K-V Pharmaceutical Comp
[ Fri, Oct 21st 2011 ] - Market Wire
AMAG Pharmaceuticals Announces Results of Special Stockholder Meeting Regarding Proposed Merger
[ Fri, Oct 21st 2011 ] - Market Wire
Dynavax and GlaxoSmithKline Expand Their Worldwide Strategic Alliance
[ Fri, Oct 21st 2011 ] - Market Wire
Wall Street Reporter, Inc. Interviews Micro Imagi .. echnology, Inc. Chairman and CEO, Michael Brennan
[ Fri, Oct 21st 2011 ] - Market Wire
AVI BioPharma's RNA-Based Therapeutics for Treatm .. ses Show Positive Safety Data in First Five of Si
[ Fri, Oct 21st 2011 ] - Market Wire
For The Earth Corporation Strengthens Its Portfolio With Kat Box King
[ Fri, Oct 21st 2011 ] - Market Wire
GTx, Inc. To Host Third Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Oct 21st 2011 ] - Market Wire
Teleflex Signs Definitive Agreement to Sell Aerospace Businesses for $280 Million
[ Fri, Oct 21st 2011 ] - Market Wire
Magellan Health Services to Present at Academy of Managed Care Pharmacy Educational Conference
[ Fri, Oct 21st 2011 ] - Market Wire
Oral BG-12 (Dimetil Fumarato) reduce notablemente .. con esclerosis multiple (MS) y el avance de la d
[ Fri, Oct 21st 2011 ] - Market Wire
Oraal toegediende BG-12 (dimethyl fumaraat) reduc .. lerose en voortschrijding aftakeling in Fase 3 DE
[ Fri, Oct 21st 2011 ] - Market Wire
Acorda Therapeutics Announces Data on AMPYRA® Pr .. h Joint Triennial Congress of ECTRIMS and ACTRIMS
[ Fri, Oct 21st 2011 ] - Market Wire
Reduzierte Schubhufigkeit und Behinderungsprogres .. durch oral verabreichtes BG-12 (Dimethylfumarat):
[ Fri, Oct 21st 2011 ] - Market Wire
Selon les observations de l'essai clinique DEFINE .. -12 (dim©thylfumarate) r©duit de manire signifi
Thu, October 20, 2011
[ Thu, Oct 20th 2011 ] - Market Wire
Biogen Idec und Elan melden Verlngerung der PDUFA-Frist
[ Thu, Oct 20th 2011 ] - Market Wire
Biogen Idec y Elan reciben notificacin de ampliacin de la fecha PDUFA
[ Thu, Oct 20th 2011 ] - Market Wire
Critical Outcome Technologies Inc. Successfully Completes Critical Study
[ Thu, Oct 20th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. on &;; Johnson and Endo Pharmaceuticals
[ Thu, Oct 20th 2011 ] - Market Wire
Dendreon Announces Webcast Presentations at Upcoming Conferences
[ Thu, Oct 20th 2011 ] - Market Wire
Biogen Idec and Elan Receive Notification of PDUFA Date Extension
[ Thu, Oct 20th 2011 ] - Market Wire
Alnylam to Webcast Presentation at the Newsmakers in the Biotech Industry 2011 Conference
[ Thu, Oct 20th 2011 ] - Market Wire
Allon Therapeutics Announces Completion of Patient Enrollment in Pivotal Trial
[ Thu, Oct 20th 2011 ] - Market Wire
POZEN Announces November 3, 2011 Webcast of Third Quarter 2011 Results
[ Thu, Oct 20th 2011 ] - Market Wire
Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial
[ Thu, Oct 20th 2011 ] - Market Wire
Cambridge Heart Announces Initial Results of OEM Module Marketing Promotion
[ Thu, Oct 20th 2011 ] - Market Wire
Manchester Heart Centre in United Kingdom Obtains VMS(TM) Heart Analysis System
[ Thu, Oct 20th 2011 ] - Market Wire
Covidien Releases Clinical Data from Largest Pros .. Plaque Excision for Treatment of Peripheral Arter
[ Thu, Oct 20th 2011 ] - Market Wire
Five Star Quality Care, Inc. Third Quarter Conference Call Scheduled for Thursday, October 27th
[ Thu, Oct 20th 2011 ] - Market Wire
Syneron kndigt weltweite Einfhrung einer neuen Ko .. echnologien fr die Gesichtsbehandlung mit dem eTw
[ Thu, Oct 20th 2011 ] - Market Wire
Device Master File for OncoSec Medical System Completed and Submitted to FDA
[ Thu, Oct 20th 2011 ] - Market Wire
Comprehensive Care Corporation CEO Clark A. Marcus Praised for U.S. Chamber of Commerce Service
Wed, October 19, 2011
[ Wed, Oct 19th 2011 ] - Market Wire
Sun Healthcare Group, Inc. to Release Third-Quarter Results for 2011 and Schedules Conference Call
[ Wed, Oct 19th 2011 ] - Market Wire
Critical Outcome Technologies Inc. Issues Stock Options to Employees
[ Wed, Oct 19th 2011 ] - Market Wire
CML HealthCare Inc. Declares October Dividend
[ Wed, Oct 19th 2011 ] - Market Wire
Gegevens over vroeg gebruik en baten op lange ter .. d op 5de gezamenlijk driejaarlijks congres over b
[ Wed, Oct 19th 2011 ] - Market Wire
Des r©sultats relatifs l'utilisation pr©coce et .. YSABRI sont pr©sent©s l'occasion du 5e Congrs t
[ Wed, Oct 19th 2011 ] - Market Wire
Los datos sobre el uso temprano y los beneficios .. sido presentados en el 5 congreso trienal conjun
[ Wed, Oct 19th 2011 ] - Market Wire
Theratechnologies Announces Application for Registration of Tesamorelin in Mexico
[ Wed, Oct 19th 2011 ] - Market Wire
Diligent Board Member Services Ranked Number 156 .. rth America on Deloitte's 2011 Technology Fast 50
[ Wed, Oct 19th 2011 ] - Market Wire
Marina Biotech Demonstrates In Vivo Dose-Dependen .. erability With a CRN-Substituted miRNA Antagonist
[ Wed, Oct 19th 2011 ] - Market Wire
Ardea Biosciences to Present Data From Gout Program at the 2011 ACR/ARHP Annual Scientific Meeting
[ Wed, Oct 19th 2011 ] - Market Wire
UNITEDHEALTHCARE OFRECE AUDFONOS SIN COSTO DE DES .. PARA LOS BENEFICIARIOS DEL CONDADO DE MIAMI-DADE
[ Wed, Oct 19th 2011 ] - Market Wire
Vertex Submits Application for Priority Review an .. 770, ivacaftor) in the U.S. as First Potential Me
[ Wed, Oct 19th 2011 ] - Market Wire
Ligand Enters into Platform Captisol® License Agreement with SAGE Therapeutics
[ Wed, Oct 19th 2011 ] - Market Wire
Single Pharmaceutical-Based Strategy Aims to Solve Neurological and Psychiatric Disorders
[ Wed, Oct 19th 2011 ] - Market Wire
Daten ber Vorteile frhzeitiger bzw. langfristiger .. f 5. dreijhrlichem gemeinsamem Kongress von ECTRI
[ Wed, Oct 19th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at BIO Investor Forum on October 26th
[ Wed, Oct 19th 2011 ] - Market Wire
Presentati al 5o congresso triennale congiunto di .. ivi alla?uso precoce e ai vantaggi a lungo termin
Tue, October 18, 2011
[ Tue, Oct 18th 2011 ] - Market Wire
Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS
[ Tue, Oct 18th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc.
[ Tue, Oct 18th 2011 ] - Market Wire
Vanda Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 4, 2011
[ Tue, Oct 18th 2011 ] - Market Wire
Cytokinetics Announces Strategic Restructuring
[ Tue, Oct 18th 2011 ] - Market Wire
Greatbatch, Inc. to Host Third Quarter 2011 Earnings Conference Call on October 27, 2011
[ Tue, Oct 18th 2011 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. vestment in Stereotaxis, Inc. to Inquire About th
[ Tue, Oct 18th 2011 ] - Market Wire
Exactech Schedules Third Quarter 2011 Earnings Release and Conference Call
[ Tue, Oct 18th 2011 ] - Market Wire
Allon Therapeutics Completes Equity Offering
[ Tue, Oct 18th 2011 ] - Market Wire
Flamel Technologies Announces Multi-Year Supply A .. ith GlaxoSmithKline for Coreg CRa" Microparticles
[ Tue, Oct 18th 2011 ] - Market Wire
MethylGene Receives FDA IND Approval to Begin a P .. ith MGCD290, a Novel Antifungal Product Candidate
[ Tue, Oct 18th 2011 ] - Market Wire
Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2011 Financial Results
[ Tue, Oct 18th 2011 ] - Market Wire
ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results
[ Tue, Oct 18th 2011 ] - Market Wire
Given Imaging Announces New Study Shows Impact of .. lCam(R) SB on Management of Symptomatic IBD Cases
[ Tue, Oct 18th 2011 ] - Market Wire
Dr. Roberto Romero, NIH Principal Investigator of .. by Columbia Laboratories, Honored with John Ding
[ Tue, Oct 18th 2011 ] - Market Wire
Reflect Scientific, Inc. Introduces Cryometrix Model B-120 Blast Freezer
[ Tue, Oct 18th 2011 ] - Market Wire
Greystone Logistics Announces Preliminary Financial Results for 1st Quarter
[ Tue, Oct 18th 2011 ] - Market Wire
DaVita Announces Estimate of Third Quarter 2011 Results
Mon, October 17, 2011
[ Mon, Oct 17th 2011 ] - Market Wire
Afexa Announces Take-Up of Shares Under Valeant Offer

Anthera Announces Third Quarter 2011 Financial Report and Conference Call


//health-fitness.news-articles.net/content/2011/ .. r-2011-financial-report-and-conference-call.html
Published in Health and Fitness on Monday, October 24th 2011 at 19:03 GMT by Market Wire   Print publication without navigation


Anthera Announces Third Quarter 2011 Financial Report and Conference Call -- HAYWARD, Calif., Oct. 24, 2011 /PRNewswire/ --

Anthera Announces Third Quarter 2011 Financial Report and Conference Call

[ ]

HAYWARD, Calif., Oct. 24, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: [ ANTH ]), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it will release its third quarter 2011 financial report and provide an update on its development programs after market close on Tuesday, November 1, 2011.  Anthera will host a conference call at 5 pm Eastern Time in conjunction with the release.

Conference Call Access:

Date:

November 1, 2011

Time:

5:00 pm Eastern Time



Domestic Dial-in:

(877) 312-8807

International Dial-in:

(253) 237-1190

Conference ID:

22066672



To access the 24-hour audio replay, U.S. and Canadian participants may dial (855) 859-2056; international participants may dial (404) 537-3406.  The conference ID for the replay is 22066672. The audio replay will be available until November 8, 2011.  

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases.  Anthera has three late stage clinical products: varespladib methyl (A-002), A-001 and blisibimod (A-623).  Varespladib methyl (A-002) and A-001 are designed to inhibit a novel enzyme target known as secretory phospholipase A2 (sPLA2).  Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease.  Blisibimod targets elevated levels of B-lymphocyte stimulator (BAFF), which have been associated with a variety of B-Cell mediated autoimmune diseases, including systemic lupus erythematosus (lupus) and rheumatoid arthritis.  

CONTACT: Bianca Nery of Anthera Pharmaceuticals, Inc., [ bnery@anthera.com ] or 510-856-5586.

SOURCE Anthera Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.anthera.com ]


Publication Contributing Sources